--Morgan Stanley Adjusts ViewRay's Price Target to $1 From $2, Keeps Equalweight Rating

--Morgan Stanley Adjusts ViewRay's Price Target to $1 From $2, Keeps Equalweight Rating

MT Newswires · 05/11/2023 06:51

Please log in to view news